These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20814462)

  • 1. Paroxetine overdose.
    Gupta AK; Verma P; Praharaj SK; Roy D; Singh A
    Indian J Psychiatry; 2005 Jul; 47(3):167-8. PubMed ID: 20814462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine overdose during pregnancy.
    Acar S; Erol H; Arslan EK; Uysal N; Karadaş B; Temiz TK; Cem Kaplan Y
    Forensic Sci Res; 2021; 6(3):237-239. PubMed ID: 34868717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpectedly Prolonged Serotonin Syndrome and Fatal Complications Following a Massive Overdose of Paroxetine Controlled-Release.
    Inoue F; Okazaki Y; Ichiba T; Kashiwa K; Namera A
    Cureus; 2023 Dec; 15(12):e50691. PubMed ID: 38229825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Serotonin Syndrome and Prolong QT Interval Induced by Paroxetine Overdose With Isotretinoin.
    Al-Radideh O; Chan KH; Gupta S; Slim J; Bellary S
    Cureus; 2021 Apr; 13(4):e14497. PubMed ID: 34007750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine: an overview of dosage, tolerability, and safety.
    Jenner PN
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():69-80. PubMed ID: 1431015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.
    Nemeroff CB
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):10S-17S. PubMed ID: 8106649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of antidepressant overdose.
    D'Mello DA; Finkbeiner DS; Kocher KN
    Gen Hosp Psychiatry; 1995 Nov; 17(6):454-5. PubMed ID: 8714807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of paroxetine.
    Boyer WF; Feighner JP
    J Clin Psychiatry; 1992 Feb; 53 Suppl():3-6. PubMed ID: 1531819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual presentation of sertraline and trazodone overdose.
    Adson DE; Erickson-Birkedahl S; Kotlyar M
    Ann Pharmacother; 2001 Nov; 35(11):1375-7. PubMed ID: 11724086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of paroxetine in three postmortem cases.
    Vermeulen T
    J Anal Toxicol; 1998 Oct; 22(6):541-4. PubMed ID: 9788532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible hepatotoxicity of paroxetine in a patient with major depression.
    Helmchen C; Boerner RJ; Meyendorf R; Hegerl U
    Pharmacopsychiatry; 1996 Nov; 29(6):223-6. PubMed ID: 8956353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety profile of paroxetine.
    Boyer WF; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():61-6. PubMed ID: 1531828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatremia following acute overdose with paroxetine.
    Johnsen CR; Hoejlyng N
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):333-5. PubMed ID: 9660041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB
    Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome.
    Eriksson E; Hedberg MA; Andersch B; Sundblad C
    Neuropsychopharmacology; 1995 Apr; 12(2):167-76. PubMed ID: 7779245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical profile of paroxetine: a novel selective serotonin reuptake inhibitor (SSRI).
    J Clin Psychiatry; 1992 Feb; 53 Suppl():1-68. PubMed ID: 1531815
    [No Abstract]   [Full Text] [Related]  

  • 17. Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer.
    Hilleret H; Voirol P; Bovier P; Giannakopoulos P; Zullino D; Baumann P; Giroud C; Rivier L; Eap CB
    Ther Drug Monit; 2002 Aug; 24(4):567-9. PubMed ID: 12142644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of Kv1.5 by paroxetine, an antidepressant drug.
    Lee HM; Hahn SJ; Choi BH
    Korean J Physiol Pharmacol; 2016 Jan; 20(1):75-82. PubMed ID: 26807026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.